American Society for Clinical Pharmacology and Therapeutics
Clinical Pharmacology & Therapeutics (1999) 65, 191–191; doi:
Central (CE) Vs. Peripheral (PE) Effects of I.V. Bolus Scopolamine (SCP) in Healthy Young and Elderly Females*
J.D. Hong BS1,*, P.W. Slattum PharmD, PhD1, S.M. Learned-Coughlin PharmD, PhD2, K. Wesnes PhD3 and J. Venitz MD, PhD1
- 1Dept of Pharmaceutics, VCU, Richmond, VA
- 2Glaxo-Wellcome, RTP, NC, CDR
- 3Reading, UK.
*Nonmember of the Society.
*Partial Support: NIH Grant M01 R00065, A.D. Williams Scholarship Foudation, and Cognitive Drug Research, UK.
